In hepatocellular carcinoma (HCC), ascorbate was shown to be preferentially active against cancer cells with a stem-cell like phenotype (Sox-2, Oct-4, Lin28, or CD133 positive) in comparison to the cancer-stem cell marker negative liver cancer cells [38]. This evidence concerns the gene SOX2 and cancer.